01
Medical AI agents in 2026: what is in use and what remains experimental
How medical AI agents differ from chatbots, which workflows are being deployed and why clinical decisions remain with people.
Read analysis ↗Knowledge base
Evidence-led analysis of products, research and patient pathways. Each article separates documented capabilities from project hypotheses and links to primary or official sources.
How medical AI agents differ from chatbots, which workflows are being deployed and why clinical decisions remain with people.
Read analysis ↗How AI can support oncology trial search and criterion matching without deciding eligibility or enrolment.
Read analysis ↗A clear guide to AI-assisted navigation across Russia’s OMS insurance, VMP high-technology care and self-pay pathways—without treatment selection.
Read analysis ↗Editorial method
We date each review, do not convert research results into proven clinical benefit and do not publish individual treatment recommendations.
How articles are prepared ↗